Why Chemed (CHE) Stock Is Down Today

Chemed Corporation (CHE) is down 4.8% today. Here is some analysis on what might have caused this price movement.

Analysis: A clear company-specific catalyst does not appear to have emerged on August 27, 2026, so the sell-off may reflect profit-taking after a strong post-earnings run. This could also be because investors are reacting to recent insider sales and option-related dispositions disclosed in August, even though Chemed’s latest quarterly results were strong and included higher full-year guidance.

Details:

Chemed’s latest quarterly release showed second-quarter 2026 revenue rising 8.8% to $673.3 million, with adjusted diluted EPS up 41.9% to $6.06.

The company raised full-year 2026 adjusted EPS guidance to a range of $25.00 to $25.75, driven mainly by stronger-than-expected performance at VITAS.

A Form 4 filed in early August showed Chief Executive Officer Kevin J. McNamara sold 2,000 shares on August 3 after exercising options and covering related obligations.

Another August Form 4 showed Vice President and Chief Legal Officer Brian C. Judkins disposed of shares tied to an option exercise and tax withholding, which may have added to a cautious trading tone.

Sources:

SEC, Chemed Corporation, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CHE Insider Trading Activity

$CHE insiders have traded $CHE stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $CHE stock by insiders over the last 6 months:

KEVIN J MCNAMARA (president and CEO) has made 0 purchases and 5 sales selling 9,500 shares for an estimated $4,364,015.
ANDREA R LINDELL sold 1,347 shares for an estimated $602,553
SPENCER S LEE (executive vice president) sold 1,000 shares for an estimated $541,040
GEORGE J III WALSH sold 500 shares for an estimated $218,915
PATRICK P GRACE sold 190 shares for an estimated $101,080

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CHE Hedge Fund Activity

We have seen 277 institutional investors add shares of $CHE stock to their portfolio, and 283 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

AQR CAPITAL MANAGEMENT LLC added 556,862 shares (+134.0%) to their portfolio in Q2 2026, for an estimated $259,352,907
JPMORGAN CHASE & CO added 403,395 shares (+inf%) to their portfolio in Q2 2026, for an estimated $187,877,187
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 344,807 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $160,590,412
BOSTON PARTNERS added 280,684 shares (+inf%) to their portfolio in Q2 2026, for an estimated $130,725,766
TWO SIGMA INVESTMENTS, LP removed 279,262 shares (-92.6%) from their portfolio in Q2 2026, for an estimated $130,063,483
NEUBERGER BERMAN GROUP LLC removed 238,376 shares (-98.5%) from their portfolio in Q2 2026, for an estimated $111,021,238
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC removed 185,066 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $86,192,638

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CHE Price Targets

Multiple analysts have issued price targets for $CHE recently. We have seen 2 analysts offer price targets for $CHE in the last 6 months, with a median target of $473.0.

Here are some recent targets:

Joanna Gajuk from B of A Securities set a target price of $510.0 on 07/09/2026
Ben Hendrix from RBC Capital set a target price of $436.0 on 04/27/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.